About this trial
Advanced stages of the response to life-threatening infection, severe trauma, or other physiological insults often lead to exhaustion of the homeostatic mechanisms that sustain normal blood pressure and oxygenation. These syndromic presentations often meet the diagnostic criteria of sepsis and/or the acute respiratory distress syndrome (ARDS), the two most common syndromes encountered in the intensive care unit (ICU). Although critical illness syndromes, such as sepsis and ARDS, have separate clinical definitions, they often overlap clinically and share several common injury mechanisms. Moreover, there are no specific therapies for critically ill patients, and as a consequence, approximately 1 in 4 patients admitted to the ICU will not survive.
The purpose of this observational study is to identify early patient biologic factors that are present at the time of ICU admission that will help diagnose critical illness syndromes earlier, identify who could benefit most from specific therapies, and enable the discovery of new treatments for syndromes such as sepsis and ARDS.
Eligibility criteria
Qualifiers
Age ≥18 years old
≤48h since ICU admission
ICU admission within 72h of presentation to the emergency department (ER)
Altered mental status (GCS<15)
Disqualifiers
Age <18 years old
>72h since ICU admission
Admission to ICU in patients >72h after the presentation to the ER
No evidence of critical illness (ICU admission due to bed-spacing)
Trial design
Treatments tested in this trial
- Phelebotomy
- Broncheoalveolar Lavage
- Tracheal Aspirate
- Rectal Swab
Treatment groups
Sponsors and collaborators
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead sponsor
London Health Sciences Centre
Collaborator
Western University, Canada
Collaborator
Western University
Collaborator